eli lilly's tirzepatide is the leader in weight loss sector 'Miracle' drugs could remake industry Research finds that patients on
Description
Paradoxically, despite greater potency, tirzepatide's GIP component may reduce nausea compared to semaglutide at equivalent effect levels
The tirzepatide clinical data consistently shows superior results in this range
[DOI] [PubMed] [Google Scholar] 16.Riley RD, Higgins JPT, Deeks JJ
Lilly says it plans to present the results at a medical meeting next year
Novo Nordisks WEGOVY (semaglutide) and Eli Lillys ZEPBOUND (tirzepatide) are reshaping the anti-obesity drug marketbut which powerhouse will claim the top spot in this high-stakes race
doi: 10.1001/jama.2017.14752
